Neuronetics Inc
NASDAQ:STIM
Neuronetics Inc
NASDAQ:STIM
Price:
3.555 USD
5.49%
Market Closed
Updated:
May 2, 2024
Neuronetics Inc
Cash from Financing Activities
|
Neuronetics Inc
Cash from Financing Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Neuronetics Inc
NASDAQ:STIM
|
Cash from Financing Activities
$22.7m
|
CAGR 3-Years
112%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.5B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-25%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Neuronetics Inc's Cash from Financing Activities?
Cash from Financing Activities
22.7m
USD
22.7m
USD
Based on the financial report for Dec 31, 2023, Neuronetics Inc's Cash from Financing Activities amounts to 22.7m USD.
What is Neuronetics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-25%
-25%
Over the last year, the Cash from Financing Activities growth was 10 708%. The average annual Cash from Financing Activities growth rates for Neuronetics Inc have been 112% over the past three years , -25% over the past five years .
You don't have any saved screeners yet
